Cargando…

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

To improve the understanding of the complex biological processes underlying the development of non-alcoholic steatohepatitis (NASH), a multi-omics approach combining bulk RNA-sequencing based transcriptomics, quantitative proteomics and single-cell RNA-sequencing was used to characterize tissue biop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ægidius, Helene M., Veidal, Sanne S., Feigh, Michael, Hallenborg, Philip, Puglia, Michele, Pers, Tune H., Vrang, Niels, Jelsing, Jacob, Kornum, Birgitte R., Blagoev, Blagoy, Rigbolt, Kristoffer T. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981216/
https://www.ncbi.nlm.nih.gov/pubmed/31980690
http://dx.doi.org/10.1038/s41598-020-58059-7
Descripción
Sumario:To improve the understanding of the complex biological processes underlying the development of non-alcoholic steatohepatitis (NASH), a multi-omics approach combining bulk RNA-sequencing based transcriptomics, quantitative proteomics and single-cell RNA-sequencing was used to characterize tissue biopsies from histologically validated diet-induced obese (DIO) NASH mice compared to chow-fed controls. Bulk RNA-sequencing and proteomics showed a clear distinction between phenotypes and a good correspondence between mRNA and protein level regulations, apart from specific regulatory events discovered by each technology. Transcriptomics-based gene set enrichment analysis revealed changes associated with key clinical manifestations of NASH, including impaired lipid metabolism, increased extracellular matrix formation/remodeling and pro-inflammatory responses, whereas proteomics-based gene set enrichment analysis pinpointed metabolic pathway perturbations. Integration with single-cell RNA-sequencing data identified key regulated cell types involved in development of NASH demonstrating the cellular heterogeneity and complexity of NASH pathogenesis.